Navigation Links
Late peak may have prevented severe flu season from becoming worse

The 2004-2005 flu season was at least as severe as the 2003-2004 season, but peaked later according to data from Solucient, a leading provider of healthcare information. This later peak may have prevented the most recent flu season from being even worse.

A flu season's severity is reflected in hospital admissions for community-acquired pneumonia (CAP), one of the most common complications of the flu. Solucient analyzed CAP discharge data from October 2002 through March 2005. The data was provided by ACTrackerTM, an online tool that provides national estimates of hospital and drug utilization approximately 45 days after the end of each month, making the estimates the most timely and current of their kind.

In the 2004-2005 flu season, daily CAP discharges peaked at an average of about 7,000 and 8,000, respectively, in January/February 2005 compared to the previous flu season's December 2003/January 2004 peak. Both these seasons had approximately 31 percent more hospital discharges than the 2002-2003 flu season.

Due to an unusual shortage of flu vaccine, the later peak of the 2004-2005 flu season may have been beneficial, allowing public health officials more time to reallocate and administer the limited supply of vaccine to those most in need -- the elderly and children. This extra time could have been responsible for preventing many more people from becoming ill than would have been expected under the circumstances if the flu peaked at the same time it did the year before.

###

To see a graph showing hospital CAP admissions for 2002-2005, go to http://www.solucient.com/trendtracker


'"/>

Source:Solucient, LLC


Page: 1

Related biology news :

1. Study reveals genomics of inflammation from severe injury
2. Study shows pine bark naturally decreases severe chronic venous insufficiency
3. New treatment for severe malaria
4. Highly concentrated botulinum preparation for cosmetic injections can result in severe illness
5. Hopkins scientists link immune response to ghost parasites and severely congested sinuses
6. New findings could lead to vaccine for severe malaria
7. MRSA toxin acquitted: Study clears suspected key to severe bacterial illness
8. Mutant gene causes severe kidney disease in infants
9. Stanford-led study closes in on genes that may predispose some people to severe depression
10. Amazon rainforest greens up in the dry season
11. Air travel and flu: Post-9/11 restrictions delayed start of season
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Late peak may have prevented severe flu season from becoming worse

(Date:6/18/2015)... , June 18, 2015 This report ... Million by the following Product Segments, which includes Immunoassay ... Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay ... US, Canada , Japan ... Asia-Pacific , Latin America , ...
(Date:6/17/2015)... HILDEN , Deutschland und GERMANTOWN, Maryland ... Investigator ®   Produktlinie mit ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... neue STR-Testkits der Produktlinie Investigator ... DNA-Spuren in den Markt eingeführt. Die neuen Kits zur ...
(Date:6/17/2015)... 17, 2015  Synaptics Inc. (NASDAQ: SYNA ... announced that Xiaomi, one of the world,s largest ... ClearPad ® family of capacitive touchscreen solutions ... (DDICs) for its latest smartphones, the Xiaomi Mi ... full in-cell display solutions and DDICs in discrete ...
Breaking Biology News(10 mins):Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... Researchers from the National Oceanography Centre, Southampton, have drawn ... distribution of a notorious deep-sea giant the king crab. ... of Biogeography , reveal temperature as a driving force behind ... and over tens of millions of years of Earth,s history. ...
... 2nd 2009. A new measurement system for the detection of ... the research vessel Polarstern. Whales are usually difficult to spot. ... their life under water. On the other hand, only a ... surface, and this can even hardly be distinguished from the ...
... assistant professor of pathology and laboratory medicine at The ... received a Career Development Award from the National Hemophilia ... into the development of a therapy for people with ... resistant to treatment. Hemophilia A affects about one in ...
Cached Biology News:Evolution: Crabs go deep to avoid hot water 2All in sight 2UT scientist receives hemophilia research award 2
(Date:7/2/2015)... ... 2015 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), a ... the acquisition of Turner Medical, Inc ., thus becoming a global leader ... Spine Industry. The acquisition of Turner Medical ideally supplements In’Tech Medical’s product offering, ...
(Date:7/1/2015)... BANGALORE, India , July 1, 2015  Strand ... next generation sequencing technology to empower cancer care, today ... as chief executive officer. In his expanded role as ... all strategy, business expansion and worldwide operations effective immediately.  ... Strand,s chairman and CEO since its founding in 2000, ...
(Date:7/1/2015)... InferMed , s decision ... augment Elsevier ... suite   Elsevier , a world-leading provider ... today the acquisition of  InferMed , a London ... InferMed,s Arezzo technology supports clinicians in choosing the most appropriate ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... take part in the first half of “Integrative Biotechnology,” an applied biotechnology course ... in summer 2014, this course combines students from both universities and is taught ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2
... Primary Endpoint Data from Phase II Study Shows 71% Objective ... - , , - Secondary Endpoint Evaluation Shows Promising ... - , , ORLANDO, Fla. and TUSTIN, Calif., June ... today announced that preliminary results from a Phase II trial ...
... Presented Today at American Society of Clinical Oncology , ... Inc. today presented data demonstrating the use of ChemoFX(R), ... (ERBITUX(R)) on the colorectal cancer cells of individual patients. ... 54 primary colorectal cultures tested, eight percent were responsive ...
... 1 PTC Therapeutics, Inc. (PTC) today announced that ... Commercial Operations. In this role, she will report ... be responsible for PTC,s patient services and distribution functions ... (Logo: http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO ) ...
Cached Biology Technology:Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 2Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 3Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 4Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 5Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 6Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients 2Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients 3PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations 2
... contains sufficient materials for 1,464 array sample elements. , ... each , Blocker BSA in PBS (10X): 50 ... , BupH Phosphate Buffered Saline: 8 packs , ... West Pico Luminol Enhancer: 2 x 25 ml , ...
... counts cells based on specific fluorescence labelling ... so that other non cellular particles do ... 250 m square quartz cuvette each cell ... used as a counting signal and information ...
... Accurate Results Laser Capture Microdissection (LCM) ... and accuracy of molecular assays by starting ... multi-cellular structures isolated from whole tissue or ... in 1996 at the National Institutes of ...
Mouse monoclonal antibody raised against a partial recombinant DHX8. NCBI Entrez Gene ID = DHX8...
Biology Products: